Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001641172-25-004857
Filing Date
2025-04-15
Accepted
2025-04-15 17:03:59
Documents
6
Period of Report
2025-04-15

Document Format Files

Seq Description Document Type Size
1 formpre14a.htm PRE 14A 622253
2 formpre14a_001.jpg GRAPHIC 23568
3 formpre14a_002.jpg GRAPHIC 1579
4 formpre14a_003.jpg GRAPHIC 1574
5 formpre14a_004.jpg GRAPHIC 1940
6 proxy_001.jpg GRAPHIC 8032
  Complete submission text file 0001641172-25-004857.txt   674550
Mailing Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217
Business Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-41463 | Film No.: 25840308
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)